183 related articles for article (PubMed ID: 12542441)
1. The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma.
Alexandrakis MG; Passam FH; Ganotakis ES; Sfiridaki K; Xilouri I; Perisinakis K; Kyriakou DS
Clin Lab Haematol; 2003 Feb; 25(1):41-6. PubMed ID: 12542441
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group.
Pelliniemi TT; Irjala K; Mattila K; Pulkki K; Rajamäki A; Tienhaara A; Laakso M; Lahtinen R
Blood; 1995 Feb; 85(3):765-71. PubMed ID: 7530507
[TBL] [Abstract][Full Text] [Related]
3. Acute phase proteins and prognosis in multiple myeloma.
Merlini G; Perfetti V; Gobbi PG; Quaglini S; Franciotta DM; Marinone G; Ascari E
Br J Haematol; 1993 Apr; 83(4):595-601. PubMed ID: 7686034
[TBL] [Abstract][Full Text] [Related]
4. Serum acute phase reactants and prognosis in renal cell carcinoma.
Ljungberg B; Grankvist K; Rasmuson T
Cancer; 1995 Oct; 76(8):1435-9. PubMed ID: 8620420
[TBL] [Abstract][Full Text] [Related]
5. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis.
Park JR; Jones JG; Hazleman BL
Ann Rheum Dis; 1981 Oct; 40(5):493-5. PubMed ID: 6171213
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
[TBL] [Abstract][Full Text] [Related]
7. Acute phase reactants in the elderly.
Milman N; Graudal N; Andersen HC
Clin Chim Acta; 1988 Aug; 176(1):59-62. PubMed ID: 2458869
[TBL] [Abstract][Full Text] [Related]
8. A comparison between erythrocyte sedimentation rate (ESR) and selected acute-phase proteins in the elderly.
Katz PR; Karuza J; Gutman SI; Bartholomew W; Richman G
Am J Clin Pathol; 1990 Nov; 94(5):637-40. PubMed ID: 1700597
[TBL] [Abstract][Full Text] [Related]
9. Serum immunoreactive interleukin-6 and C-reactive protein levels in patients with multiple myeloma at diagnosis.
Tienhaara A; Pulkki K; Mattila K; Irjala K; Pelliniemi TT
Br J Haematol; 1994 Feb; 86(2):391-3. PubMed ID: 8199033
[TBL] [Abstract][Full Text] [Related]
10. Acute-phase proteins and incidence of diabetes: a population-based cohort study.
Muhammad IF; Borné Y; Hedblad B; Nilsson PM; Persson M; Engström G
Acta Diabetol; 2016 Dec; 53(6):981-989. PubMed ID: 27581604
[TBL] [Abstract][Full Text] [Related]
11. Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma.
Ljungberg B; Grankvist K; Rasmuson T
Eur J Cancer; 1997 Oct; 33(11):1794-8. PubMed ID: 9470835
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and acute-phase proteins in head and neck cancer.
Gallo O; Gori AM; Attanasio M; Martini F; Giusti B; Brunelli T; Gallina E
Eur Arch Otorhinolaryngol; 1995; 252(3):159-62. PubMed ID: 7544987
[TBL] [Abstract][Full Text] [Related]
13. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
[TBL] [Abstract][Full Text] [Related]
14. Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activity.
Alexandrakis MG; Passam FH; Kyriakou DS; Christophoridou AV; Perisinakis K; Hatzivasili A; Foudoulakis A; Castanas E
Am J Hematol; 2004 Feb; 75(2):101-6. PubMed ID: 14755377
[TBL] [Abstract][Full Text] [Related]
15. [Values of Detecting the Levels of β2-MG, TNF-α, CRP, IL-6 in the Patients with Multiple Myeloma].
Duan LJ; Li C; Yang RY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1362-5. PubMed ID: 26524038
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of circulating endothelial adhesion molecules (sE-selectin and sICAM) in untreated multiple myeloma patients.
Alexandrakis MG; Passam FH; Sfiridaki K; Kafarakis P; Karydi E; Liapi D; Perisinakis K; Kyriakou DS
Clin Chim Acta; 2004 Nov; 349(1-2):39-43. PubMed ID: 15469853
[TBL] [Abstract][Full Text] [Related]
17. Acute phase reactant proteins in differential diagnosis of monoclonal gammopathy.
San Miguel J; Corrales A; Alberca I; Vicente V; Lopez Borrasca A
Neoplasma; 1983; 30(1):57-62. PubMed ID: 6403877
[TBL] [Abstract][Full Text] [Related]
18. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis.
Sheehan NJ; Slavin BM; Donovan MP; Mount JN; Mathews JA
Br J Rheumatol; 1986 May; 25(2):171-4. PubMed ID: 2423177
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and staging systems of multiple myeloma:
Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
